ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Minutoli, Letteria ^a   Puzzolo, Domenico ^b   Rinaldi, Mariagrazia ^a   Irrera, Natasha ^a   Marini, Herbert ^a   Arcoraci, Vincenzo ^a   Bitto, Alessandra ^a   Crea, Giovanni ^b   Pisani, Antonina ^b   Squadrito, Francesco ^a   Trichilo, Vincenzo ^a   Bruschetta, Daniele ^b   Micali, Antonio ^b   Altavilla, Domenica ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELL DEATH; CHEMICAL ACTIVATION; TISSUE;

CELLULAR CHANGES; INFLAMMATORY RESPONSE; ISCHEMIA/REPERFUSION; ISCHEMIC TISSUES; NORMAL CONDITION; REACTIVE OXYGEN SPECIES; STATE OF THE ART; TISSUE INFLAMMATION;

TISSUE HOMEOSTASIS;

CRYOPYRIN; INFLAMMASOME; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BRAIN INJURY; CARDIAC MUSCLE CELL; CELL DEATH; HEART INJURY; HUMAN; INFLAMMATION; KIDNEY INJURY; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TESTIS INJURY; TESTIS TORSION; ANIMAL; BRAIN; CARDIAC MUSCLE; KIDNEY; MALE; METABOLISM; PATHOLOGY; TESTIS;

ANIMALS; BRAIN; INFLAMMASOMES; KIDNEY; MALE; MYOCARDIUM; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; TESTIS;

EID: 84965131131     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/2183026     Document Type: Review

References (102)

1. H. K. Eltzschig and T. Eckle, "Ischemia and reperfusion-from mechanism to translation, " Nature Medicine, vol. 17, no. 11, pp. 1391-1401, 2011.
2. T. Kalogeris, C. P. Baines, M. Krenz, and R. J. Korthuis, "Cell biology of ischemia/reperfusion injury, " International Review of Cell and Molecular Biology, vol. 298, pp. 229-317, 2012.
3. D. L. Carden and D. N. Granger, "Pathophysiology of ischaemia-reperfusion injury, "TheJournal of Pathology, vol. 190, no. 3, pp. 255-266, 2000.
4. X. Lei, H. Chao, Z. Zhang et al., "Neuroprotective effects of quercetin in a mouse model of brain ischemic/reperfusion injury via anti-apoptotic mechanisms based on the Akt pathway, " Molecular Medicine Reports, vol. 12, no. 3, pp. 3688-3696, 2015.
5. F. Martinon, "Signaling by ROS drives inflammasome activation, " European Journal of Immunology, vol. 40, no. 3, pp. 616-619, 2010.
6. P. D. Ray, B.-W. Huang, and Y. Tsuji, "Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling, " Cellular Signalling, vol. 24, no. 5, pp. 981-990, 2012.
7. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, "Free radicals and antioxidants in normal physiological functions and human disease, " International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44-84, 2007.
8. J. Limón-Pacheco and M. E. Gonsebatt, "The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress, " Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 674, no. 1-2, pp. 137-147, 2009.
9. R. Dringen, "Metabolism and functions of glutathione in brain, " Progress in Neurobiology, vol. 62, no. 6, pp. 649-671, 2000.
10. J. Jurado, M.-J. Prieto-Alamo, J. Madrid-Rísquez, and C. Pueyo, "Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse, " The Journal of Biological Chemistry, vol. 278, no. 46, pp. 45546-45554, 2003.
11. C. Bryant and K. A. Fitzgerald, "Molecular mechanisms involved in inflammasome activation, " Trends in Cell Biology, vol. 19, no. 9, pp. 455-464, 2009.
12. C. Bourgeois and K. Kuchler, "Fungal pathogens-a sweet and sour treat for toll-like receptors, " Frontiers in Cellular and Infection Microbiology, vol. 2, p. 142, 2012.
13. J. Cui, Y. Chen, H. Y. Wang, and R.-F. Wang, "Mechanisms and pathways of innate immune activation and regulation in health and cancer, "HumanVaccines&Immunotherapeutics, vol. 10, no. 11, pp. 3270-3285, 2014.
14. F. Martinon, K. Burns, and J. Tschopp, "The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-, " Molecular Cell, vol. 10, no. 2, pp. 417-426, 2002.
15. B. Z. Shao, Z. Q. Xu, B. Z. Han, D. F. Su, and C. Liu, "NLRP3 inflammasome and its inhibitors: a review, " Frontiers in Pharmacology, vol. 6, article 262, 2015.
16. E. Ozaki, M. Campbell, and S. L. Doyle, "Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives, " Journal of Inflammation Research, vol. 8, pp. 15-27, 2015.
17. J. M. Kahlenberg, K. C. Lundberg, S. B. Kertesy, Y. Qu, and G. R. Dubyak, "Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-Bdriven protein synthesis, " Journal of Immunology, vol. 175, no. 11, pp. 7611-7622, 2005.
18. F. G. Bauernfeind, G. Horvath, A. Stutz et al., "Cutting edge: NF-B activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression, " Journal of Immunology, vol. 183, no. 2, pp. 787-791, 2009.
19. H. Zhao, J. S. Perez, K. Lu, A. J. T. George, and D. Ma, "Role of toll-like receptor-4 in renal graft ischemia-reperfusion injury, " American Journal of Physiology-Renal Physiology, vol. 306, no. 8, pp. F801-F811, 2014.
20. G. Vilahur and L. Badimon, "Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor, " Frontiers in Physiology, vol. 5, article 496, 2014.
21. A. Rubartelli, "Redox control of NLRP3 inflammasome activation in health and disease, " Journal of Leukocyte Biology, vol. 92, no. 5, pp. 951-958, 2012.
22. K. Schroder and J. Tschopp, "Theinflammasomes, " Cell, vol. 140, no. 6, pp. 821-832, 2010.
23. Q. Zheng, Y. Ren, P. S. Reinach et al., "Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye, " Experimental Eye Research, vol. 125, pp. 1-8, 2014.
24. L. Niu, S. Zhang, J. Wu, L. Chen, and Y. Wang, "Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients, " PLoS ONE, vol. 10, no. 5, Article IDe0126277, 2015.
25. C. He andD. J. Klionsky, "Regulationmechanisms and signaling pathways of autophagy, " Annual Review of Genetics, vol. 43, pp. 67-93, 2009.
26. H.-J. Anders and D. A. Muruve, "Theinflammasomes in kidney disease, " Journal of the American Society of Nephrology, vol. 22, no. 6, pp. 1007-1018, 2011.
27. A. J. S. Choi and S. W. Ryter, "Inflammasomes: molecular regulation and implications for metabolic and cognitive diseases, " Molecules and Cells, vol. 37, no. 6, pp. 441-448, 2014.
28. J. Rivers-Auty and D. Brough, "Potassiumefflux fires the canon: potassium efflux as a common trigger for canonical and noncanonical NLRP3 pathways, " European Journal of Immunology, vol. 45, no. 10, pp. 2758-2761, 2015.
29. O. Gross, C. J. Thomas, G. Guarda, and J. Tschopp, "The inflammasome: an integrated view, " Immunological Reviews, vol. 243, no. 1, pp. 136-151, 2011.
30. J. Tschopp and K. Schroder, "NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production" Nature Reviews Immunology, vol. 10, no. 3, pp. 210-215, 2010.
31. J. Zhou and W.-J. Chng, "Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer, " Mitochondrion, vol. 13, no. 3, pp. 163-169, 2013.
32. H.-J. Kim, D. W. Lee, K. Ravichandran et al., "NLRP3 Inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury, " Journal of Pharmacology and Experimental Therapeutics, vol. 346, no. 3, pp. 465-472, 2013.
33. C. M. Turner, N. Arulkumaran, M. Singer, R. J. Unwin, and F. W. Tam, "Is the inflammasome a potential therapeutic target in renal disease" BMC Nephrology, vol. 15, article 21, 2014.
34. M. Ahmad, N. J. Dar, Z. S. Bhat et al., "Inflammation in ischemic stroke: mechanisms, consequences and possible drug targets, " CNS and Neurological Disorders-Drug Targets, vol. 13, no. 8, pp. 1378-1396, 2014.
35. H. Marini, D. Altavilla, M. Bellomo et al., "Modulation of IL-1 gene expression by lipid peroxidation inhibition after kainic acid-induced rat brain injury, " ExperimentalNeurology, vol. 188, no. 1, pp. 178-186, 2004.
36. B. Fogal and S. J. Hewett, "Interleukin-1: a bridge between inflammation and excitotoxicity" Journal of Neurochemistry, vol. 106, no. 1, pp. 1-23, 2008.
37. A. Denes, P. Thornton, N. J. Rothwell, and S. M. Allan, "Inflammation and brain injury: acute cerebral ischaemia, peripheral, and central inflammation, " Brain, Behavior, and Immunity, vol. 24, no. 5, pp. 708-723, 2010.
38. R. von Bernhardi, L. Eugenín-von Bernhardi, and J. Eugenín, "Microglial cell dysregulation in brain aging and neurodegeneration, " Frontiers in Aging Neuroscience, vol. 7, article 124, 2015.
39. D. Brough, R. A. Le Feuvre, Y. Iwakura, and N. J. Rothwell, "Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism, "Molecular and Cellular Neuroscience, vol. 19, no. 2, pp. 272-280, 2002.
40. V. Hornung and E. Latz, "Critical functions of priming and lysosomal damage for NLRP3 activation, " European Journal of Immunology, vol. 40, no. 3, pp. 620-623, 2010.
41. C. D. Savage, G. Lopez-Castejon, A. Denes, and D. Brough, "NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury, " Frontiers in Immunology, vol. 3, article 288, 2012.
42. D. Yang-Wei Fann, S.-Y. Lee, S. Manzanero et al., "Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke, " Cell Death & Disease, vol. 4, no. 9, article e790, 2013.
43. D. Y.-W. Fann, T. Santro, S. Manzanero et al., "Intermittent fasting attenuates inflammasome activity in ischemic stroke, " Experimental Neurology, vol. 257, pp. 114-119, 2014.
44. F. Yang, Z. Wang, X. Wei et al., "NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke, " Journal of Cerebral Blood Flow&Metabolism, vol. 34, no. 4, pp. 660-667, 2014.
45. M. Ito, T. Shichita, M. Okada et al., "Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury, " Nature Communications, vol. 6, article 7360, 2015.
46. A. F. Herrera and E. D. Jacobsen, "Ibrutinib for the treatment of mantle cell lymphoma, " Clinical Cancer Research, vol. 20, no. 21, pp. 5365-5371, 2014.
47. A. Abderrazak, T. Syrovets, D. Couchie et al., "NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases, " Redox Biology, vol. 4, pp. 296-307, 2015.
48. Y. Li, J. Li, S. Li et al., "Curcumin attenuates glutamate neurotoxicity in the hippocampus by suppression of ER stress-associated TXNIP/NLRP3 inflammasome activation in a manner dependent on AMPK, " Toxicology and Applied Pharmacology, vol. 286, no. 1, pp. 53-63, 2015.
49. X. Wang, R. Li, X. Wang, Q. Fu, and S. Ma, "Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome, " Neuroscience Letters, vol. 600, pp. 182-187, 2015.
50. T. Ishrat, I. N. Mohamed, B. Pillai et al., "Thioredoxininteracting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice, " Molecular Neurobiology, vol. 51, no. 2, pp. 766-778, 2015.
51. J. Zhao, Y. Mou, J. D. Bernstock et al., "Synthetic oligodeoxynucleotides containing multiple telemeric TTAGGG motifs suppress inflammasome activity in macrophages subjected to oxygen and glucose deprivation and reduce ischemic brain injury in stroke-prone spontaneously hypertensive rats, " PLoS ONE, vol. 10, no. 10, Article ID e0140772, 2015.
52. O. Sandanger, E. Gao, T. Ranheim et al., "NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective, " Biochemical and Biophysical Research Communications, vol. 469, no. 4, pp. 1012-1020, 2016.
53. S. M. Davidson, D. M. Yellon, M. P. Murphy, and M. R. Duchen, "Slow calcium waves and redox changes precedemitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation, " Cardiovascular Research, vol. 93, no. 3, pp. 445-453, 2012.
54. K. Zhan, P. Yu, C. Liu, J. Luo, and W. Yang, "Detrimental or beneficial: the role of TRPM2 in ischemia/reperfusion injury, " Acta Pharmacologica Sinica, vol. 37, no. 1, pp. 4-12, 2016.
55. Y. Wang, Y. Wu, J. Chen, S. Zhao, and H. Li, "Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 Inflammasome formation, " Cardiology, vol. 126, no. 1, pp. 1-11, 2013.
56. M. Takahashi, "Role of the inflammasome inmyocardial infarction, " Trends in CardiovascularMedicine, vol. 21, no. 2, pp. 37-41, 2011.
57. S. Toldo, C. Marchetti, and A. Abbate, "Re. 'NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective', " Biochemical and Biophysical Research Communications, vol. 470, no. 4, pp. 811-812, 2016.
58. B. J. Pomerantz, L. L. Reznikov, A. H. Harken, and C. A. Dinarello, "Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1, " Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2871-2876, 2001.
59. M. Kawaguchi, M. Takahashi, T. Hata et al., "Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury, " Circulation, vol. 123, no. 6, pp. 594-604, 2011.
60. K. Venkatachalam, S. D. Prabhu, V. S. Reddy, W. H. Boylston, A. J. Valente, and B. Chandrasekar, "Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury, "The Journal of Biological Chemistry, vol. 284, no. 12, pp. 7853-7865, 2009.
61. M. Wang, T. A. Markel, and D. R. Meldrum, "Interleukin 18 in the heart, " Shock, vol. 30, no. 1, pp. 3-10, 2008.
62. H. Gu, M. Xie, L. Xu, X. Zheng, Y. Yang, and X. Lv, "The protective role of interleukin-18 binding protein in a murine model of cardiac ischemia/reperfusion injury, " Transplant International, vol. 28, no. 12, pp. 1436-1444, 2015.
63. Y. Liu, K. Lian, L. Zhang et al., "TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury, " Basic Research in Cardiology, vol. 109, no. 5, p. 415, 2014.
64. J. Yoshioka, W. A. Chutkow, S. Lee et al., "Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemiareperfusion injury, "The Journal of Clinical Investigation, vol. 122, no. 1, pp. 267-279, 2012.
65. D. M. Yellon and D. J. Hausenloy, "Myocardial reperfusion injury, " The New England Journal of Medicine, vol. 357, no. 11, pp. 1074-1135, 2007.
66. S. Matsushima, J. Kuroda, T. Ago et al., "Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxiainducible factor-1 and upregulation of peroxisome proliferator-activated receptor-, " Circulation Research, vol. 112, no. 8, pp. 1135-1149, 2013.
67. W. Dong, R. Yang, J. Yang et al., "Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway, " International Journal of Clinical and Experimental Pathology, vol. 8, no. 8, pp. 8731-8741, 2015.
68. L. F. Tirapelli, D. F. Barione, B. F. M. Trazzi et al., "Comparison of twomodels for evaluation histopathology of experimental renal ischemia, " Transplantation Proceedings, vol. 41, no. 10, pp. 4083-4087, 2009.
69. G. Sener, A. Ö. Sehirli, M. Keyer-Uysal, S. Arbak, Y. Ersoy, and B. C. Yegen, "The protective effect of melatonin on renal ischemia-reperfusion injury in the rat, " Journal of Pineal Research, vol. 32, no. 2, pp. 120-126, 2002.
70. R. W. Schrier, W. Wang, B. Poole, and A. Mitra, "Acute renal failure: definitions, diagnosis, pathogenesis, and therapy, " The Journal of Clinical Investigation, vol. 114, no. 1, pp. 5-14, 2004.
71. C. Chu, W. He, Y. Kuang, K. Ren, and X. Gou, "Celastrolprotects kidney against ischemia-reperfusion-induced injury in rats, " Journal of Surgical Research, vol. 186, no. 1, pp. 398-407, 2014.
72. J. J. Friedewald and H. Rabb, "Inflammatory cells in ischemic acute renal failure, " Kidney International, vol. 66, no. 2, pp. 486-491, 2004.
73. J. V. Bonventre and A. Zuk, "Ischemic acute renal failure: an inflammatory disease" Kidney International, vol. 66, no. 2, pp. 480-485, 2004.
74. G. C. Gobe and D. W. Johnson, "Distal tubular epithelial cells of the kidney: potential support for proximal tubular cell survival after renal injury, " International Journal of Biochemistry and Cell Biology, vol. 39, no. 9, pp. 1551-1561, 2007.
75. S. S. Iyer, W. P. Pulskens, J. J. Sadler et al., "Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome, " Proceedings of theNational Academy of Sciences of theUnited States ofAmerica, vol. 106, no. 48, pp. 20388-20393, 2009.
76. D. Singh and K. Chopra, "The effect of naringin, a bioflavonoid on ischemia-reperfusion induced renal injury in rats, " Pharmacological Research, vol. 50, no. 2, pp. 187-193, 2004.
77. L. Kabasakal, Ö. Sehirli, S. Cetinel, E. Cikler, N. Gedik, and G. Sener, "Protective effect of aqueous garlic extract against renal ischemia/reperfusion injury in rats, " Journal of Medicinal Food, vol. 8, no. 3, pp. 319-326, 2005.
78. A. Korkmaz and D. Kolankaya, "Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney, " Journal of Surgical Research, vol. 164, no. 2, pp. 309-315, 2010.
79. S. Yang, W.-P. Chou, and L. Pei, "Effects of propofol on renal ischemia/reperfusion injury in rats, " Experimental and Therapeutic Medicine, vol. 6, no. 5, pp. 1177-1183, 2013.
80. E. K. Choi, H. Jung, K. H. Kwak et al., "Effects of allopurinol and apocynin on renal ischemia-reperfusion injury in rats, " Transplantation Proceedings, vol. 47, no. 6, pp. 1633-1638, 2015.
81. M. Sandovici, R. H. Henning, H. van Goor, W. Helfrich, D. de Zeeuw, and L. E. Deelman, "Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injury, " Kidney International, vol. 73, no. 12, pp. 1364-1373, 2008.
82. H. Wu, M. L. Craft, P. Wang et al., "IL-18 contributes to renal damage after ischemia-reperfusion, " Journal of the American Society of Nephrology, vol. 19, no. 12, pp. 2331-2341, 2008.
83. P. J. Bakker, L. M. Butter, N. Claessen et al., "A tissuespecific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion, " The American Journal of Pathology, vol. 184, no. 7, pp. 2013-2022, 2014.
84. A. A. Shigeoka, J. L. Mueller, A. Kambo et al., "An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury, " The Journal of Immunology, vol. 185, no. 10, pp. 6277-6285, 2010.
85. L. Minutoli, P. Antonuccio, F. Polito et al., "Mitogen-activated protein kinase 3/mitogen-activated protein kinase 1 activates apoptosis during testicular ischemia-reperfusion injury in a nuclear factor-B-independent manner, " European Journal of Pharmacology, vol. 604, no. 1-3, pp. 27-35, 2009.
86. J. J. Lysiak, "The role of tumor necrosis factor-alpha and interleukin-1 in the mammalian testis and their involvement in testicular torsion and autoimmune orchitis, " Reproductive Biology and Endocrinology, vol. 2, article 9, 2004.
87. S. Ozbal, B. U. Ergur, G. Erbil, I. Tekmen, A. Bagryank, and Z. Cavdar, "The effects of-lipoic acid against testicular ischemiareperfusion injury in rats, " The Scientific World Journal, vol. 2012, Article ID 489248, 8 pages, 2012.
88. B. McDonald, K. Pittman, G. B. Menezes et al., "Intravascular danger signals guide neutrophils to sites of sterile inflammation, " Science, vol. 330, no. 6002, pp. 362-366, 2010.
89. J. G. Reyes, J. G. Farias, S. Henríquez-Olavarrieta et al., "The hypoxic testicle: physiology and pathophysiology, " Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 929285, 15 pages, 2012.
90. P. Antonuccio, L. Minutoli, C. Romeo et al., "Lipid peroxidation activates mitogen-activated protein kinases in testicular ischemia-reperfusion injury, " The Journal of Urology, vol. 176, no. 4, part 1, pp. 1666-1672, 2006.
91. A. K. Srinivasan, J. Freyle, J. S. Gitlin, and L. S. Palmer, "Climatic conditions and the risk of testicular torsion in adolescentmales, " The Journal of Urology, vol. 178, no. 6, pp. 2585-2588, 2007.
92. L. Minutoli, P. Antonuccio, F. Squadrito et al., "Effects of polydeoxyribonucleotide on the histological damage and the altered spermatogenesis induced by testicular ischaemia and reperfusion in rats, " International Journal of Andrology, vol. 35, no. 2, pp. 133-144, 2012.
93. S.-M. Wei, Z.-Z. Yan, and J. Zhou, "Beneficial effect of taurine on testicular ischemia-reperfusion injury in rats, " Urology, vol. 70, no. 6, pp. 1237-1242, 2007.
94. H. Aksoy, T. Yapanoglu, Y. Aksoy, I. Özbey, H. Turhan, and N. Gursan, "Dehydroepiandrosterone treatment attenuates reperfusion injury after testicular torsion and detorsion in rats, " Journal of Pediatric Surgery, vol. 42, no. 10, pp. 1740-1744, 2007.
95. S.-M. Wei, Z.-Z. Yan, and J. Zhou, "Curcumin attenuates ischemia-reperfusion injury in rat testis, " Fertility and Sterility, vol. 91, no. 1, pp. 271-277, 2009.
96. S.-M. Wei, Z.-Z. Yan, and J. Zhou, "Psoralea corylifolia protects against testicular torsion/detorsion-induced ischemia/reperfusion injury, " Journal of Ethnopharmacology, vol. 137, no. 1, pp. 568-574, 2011.
97. S.-M. Wei, Z.-Z. Yan, and J. Zhou, "Protective effect of rutin on testicular ischemia-reperfusion injury, " Journal of Pediatric Surgery, vol. 46, no. 7, pp. 1419-1424, 2011.
98. M. Ayan, U. Tas, E. Sogut et al., "Protective effect of thymoquinone against testicular torsion induced oxidative injury, " Andrologia, vol. 48, no. 2, pp. 143-151, 2016.
99. T. E. Sener, M. Yüksel, N. Özylmaz-Yay et al., "Apocynin attenuates testicular ischemia-reperfusion injury in rats, " Journal of Pediatric Surgery, vol. 50, no. 8, pp. 1382-1387, 2015.
100. C. Juliana, T. Fernandes-Alnemri, J. Wu et al., "Anti-inflammatory compounds parthenolide and bay 11-7082 are direct inhibitors of the inflammasome, " Journal of Biological Chemistry, vol. 285, no. 13, pp. 9792-9802, 2010.
101. J. Zhao, H. Wang, C. Dai et al., "P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway, " Arthritis & Rheumatism, vol. 65, no. 12, pp. 3176-3185, 2013.
102. L. Minutoli, P. Antonuccio, N. Irrera et al., "NLRP3 Inflammasome involvement in the organ damage and impaired spermatogenesis induced by testicular ischemia and reperfusion in mice, " Journal of Pharmacology and Experimental Therapeutics, vol. 355, no. 3, pp. 370-380, 2015.